Evidence map›Paper›PMID 24358021›Full record

ArticlePLoS biology2013

Polycomb protein SCML2 regulates the cell cycle by binding and modulating CDK/CYCLIN/p21 complexes.

Emilio Lecona, Luis Alejandro Rojas, Roberto Bonasio, Andrew Johnston, Oscar Fernández-Capetillo, Danny Reinberg

Open access · goldAbstract read
In one paragraph

Article in PLoS biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. CDK2-Mediated Phosphorylation ofResearch (Washington, D.C.) · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. International journal of molecular sciences · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. USP7 is a SUMO deubiquitinase essential for DNA replication.Nature structural & molecular biology · 2016
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Emilio LeconaHoward Hughes Medical Institute, Department of Biochemistry, New York University School of Medicine, New York, New York, United States of America ; Spanish National Cancer Research Centre (CNIO), Molecular Oncology Programme, Madrid, Spain.
Luis Alejandro RojasHoward Hughes Medical Institute, Department of Biochemistry, New York University School of Medicine, New York, New York, United States of America.
Roberto BonasioHoward Hughes Medical Institute, Department of Biochemistry, New York University School of Medicine, New York, New York, United States of America.
Andrew JohnstonHoward Hughes Medical Institute, Department of Biochemistry, New York University School of Medicine, New York, New York, United States of America.
Oscar Fernández-CapetilloSpanish National Cancer Research Centre (CNIO), Molecular Oncology Programme, Madrid, Spain.
Danny ReinbergHoward Hughes Medical Institute, Department of Biochemistry, New York University School of Medicine, New York, New York, United States of America.
Howard Hughes Medical Institute · USNew York University · USSpanish National Cancer Research Centre · ES

Funding

Initiation of Transcription of Protein Coding GenesR37GM037120 · NIGMS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI REINBERG, DANNY · 2004 to 2013
$4.5M
Transcription Regulation by NC2R01GM064844 · NIGMS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI REINBERG, DANNY · 2002 to 2014
$3.3M
INITIATION OF TRANSCRIPTION OF PROTEIN CODING GENESR01GM037120 · NIGMS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI REINBERG, DANNY F · 1986 to 2001
$634k
Howard Hughes Medical InstituteNIGMS NIH HHS GM064844NIGMS NIH HHS GM37120NIGMS NIH HHS R01 GM037120NIGMS NIH HHS R01 GM064844NIGMS NIH HHS R37 GM037120
6 · The paper itself

Abstract

Polycomb group (PcG) proteins are transcriptional repressors of genes involved in development and differentiation, and also maintain repression of key genes involved in the cell cycle, indirectly regulating cell proliferation. The human SCML2 gene, a mammalian homologue of the Drosophila PcG protein SCM, encodes two protein isoforms: SCML2A that is bound to chromatin and SCML2B that is predominantly nucleoplasmic. Here, we purified SCML2B and found that it forms a stable complex with CDK/CYCLIN/p21 and p27, enhancing the inhibitory effect of p21/p27. SCML2B participates in the G1/S checkpoint by stabilizing p21 and favoring its interaction with CDK2/CYCE, resulting in decreased kinase activity and inhibited progression through G1. In turn, CDK/CYCLIN complexes phosphorylate SCML2, and the interaction of SCML2B with CDK2 is regulated through the cell cycle. These findings highlight a direct crosstalk between the Polycomb system of cellular memory and the cell-cycle machinery in mammals.

Indexed as

AnimalsCell CycleCyclin-Dependent Kinase Inhibitor p21Cyclin-Dependent KinasesCyclinsDrosophila melanogasterDrosophila ProteinsG1 PhaseHeLa CellsHumansPhosphorylationPolycomb-Group ProteinsCyclin-Dependent Kinase Inhibitor p21Cyclin-Dependent KinasesCyclinsDrosophila ProteinsPolycomb-Group ProteinsSCML2 protein, humanSCM protein, Drosophila

Identifiers

PMID24358021
PMCPMC3866099
OpenAlexW2024605154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.